Glioblastoma trials in China

In China 58 Also abroad 424

58 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
Where
Beijing
Age
18 years to 70 years
People
26
Run by
Tasly Pharmaceutical Group Co., Ltd
See details and how to joinNCT07318818
Phase 1/2Taking people
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Where
Beijing
Age
8 years to 85 years
People
85
Run by
Essen Biotech
See details and how to joinNCT07410494
Phase 1/2Taking people
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Where
Beijing
People
83
Run by
Essen Biotech
See details and how to joinNCT07410676
No phaseTaking people
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
Where
Shenyang
Age
18 years to 80 years
People
20
Run by
Shengjing Hospital
See details and how to joinNCT05957679
Phase 1/2Taking people
Clinical Study of Oncolytic Virus in Glioblastoma
Where
Mianyang
Age
18 years to 70 years
People
20
Run by
Mianyang Central Hospital
See details and how to joinNCT07145047
No phaseTaking people
Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion
Where
Shenyang
Age
18 years to 80 years
People
100
Run by
Shengjing Hospital
See details and how to joinNCT05990244
Early phase 1Not yet taking people in China
Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma
Where
Hangzhou
Age
19 years to 70 years
People
36
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07244666
Phase 1Taking people
B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
Where
Hangzhou
Age
18 years to 75 years
People
14
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07193628
Phase 2Taking people
Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread
Where
Hangzhou
Age
18 years to 75 years
People
38
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07193654
No phaseTaking people
Allogeneic γδT Cells in Glioblastoma
Where
Beijing, Zhengzhou
Age
18 years to 70 years
People
18
Run by
Peking University Third Hospital
See details and how to joinNCT07144735
Phase 2Enrolling by invitation
Sonodynamic-Chemoradiotherapy Integration in Glioblastoma
Where
Zhengzhou
Age
Up to 75 years
People
230
Run by
Yingjuan Zheng
See details and how to joinNCT07130149
Early phase 1Taking people
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
Where
Beijing
Age
18 years and over
People
15
Run by
Chinese PLA General Hospital
See details and how to joinNCT07067905
Phase 1Taking people
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
Where
Beijing
Age
18 years and over
People
40
Run by
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
See details and how to joinNCT06773481
Phase 1Taking people
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
Where
Beijing, Changchun
Age
18 years and over
People
102
Run by
Chipscreen Biosciences, Ltd.
See details and how to joinNCT06902350
Phase 2Taking people
A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
Where
Beijing
Age
18 years and over
People
20
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06598787
No phaseNot yet taking people in China
Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
Where
Hangzhou
Age
18 years and over
People
100
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT06939400
Phase 2Taking people
Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression
Where
Hangzhou
Age
18 years and over
People
200
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06936046
Phase 1/2Enrolling by invitation
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
Where
Jinan
Age
18 years and over
People
100
Run by
Man Hu
See details and how to joinNCT06690216
Early phase 1Taking people
Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
Where
Wuhan
Age
18 years and over
People
15
Run by
Zhongnan Hospital
See details and how to joinNCT06757153
No phaseTaking people
Hypofractionated Radiotherapy
Where
Changchun
Age
18 years to 70 years
People
420
Run by
The First Hospital of Jilin University
See details and how to joinNCT06740955
Phase 1/2Taking people
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Where
Beijing
Age
16 years to 90 years
People
85
Run by
Essen Biotech
See details and how to joinNCT06640582
Phase 1Enrolling by invitation
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
Where
Beijing
Age
18 years and over
People
50
Run by
Shanghai Simnova Biotechnology Co.,Ltd.
See details and how to joinNCT06616727
Phase 2Taking people
JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
Where
Beijing
Age
18 years to 75 years
People
25
Run by
JenKem Technology Co., Ltd.
See details and how to joinNCT06595186
No phaseTaking people
Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients
Where
Guangzhou
Age
18 years to 70 years
People
20
Run by
First Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT05990556
No phaseNot yet taking people in China
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
Where
Shanghai
Age
18 years to 80 years
People
326
Run by
Huashan Hospital
See details and how to joinNCT06368934